79612-79-6

Upstream product

• 36239-09-5 ethyl chlorocarbonylacetate 
• 106-40-1 4-bromo-aniline 
• 105-53-3 diethyl malonate 

Downstream Products

• 54675-23-9 6-bromo-4-hydroxyquinoline-2(1H)-one 
• 1266620-09-0 C₁₈H₂₆BrN₃O₂ 
• 79613-04-0 2-Ethoxycarbonyl-3-anilino-3-methylthio-acrylsaeure-p-bromanilid 
• 79612-87-6 2-(4-Bromo-phenylcarbamoyl)-3,3-bis-ethylsulfanyl-acrylic acid ethyl ester 
• 79612-96-7 N-(4-Bromo-phenyl)-2-[1,3]dithian-2-ylidene-malonamic acid ethyl ester 
• 79612-89-8 N-(4-Bromo-phenyl)-2-[1,3]dithiolan-2-ylidene-malonamic acid ethyl ester 
• 79612-80-9 2-(4-Bromo-phenylcarbamoyl)-3,3-bis-methylsulfanyl-acrylic acid ethyl ester 
• 79612-99-0 2-Ethoxycarbonyl-2-(4-bromphenyl-carbamoyl)-dithioessigsaeuremethylester 
• 95262-09-2 3-[(4-bromophenyl)amino]-3-oxopropanoic acid 
• 103-88-8 4-bromoacetanilide 

Relevant academic research and scientific papers

SYNTHESIS AND PROPERTIES OF AMIDES OF 2-SUBSTITUTED 3-ARYL- AND 3-PYRIDYLAMINOACRYLIC ACIDS

The reaction of aryl- or pyridylamines with ethyl orthoformate and malonanilic acid gave amides of 2-(N-arylcarbamoyl)-, 2-cyano-, 2-ethoxycarbonyl-3-aryloaminoacrylic acids and their corresponding 3-pyridyl analogs.IR and PMR spectroscopy indicates that

HCV NS3 protease inhibitors

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.

HCV NS3 PROTEASE INHIBITORS

The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections.

Design, synthesis and biological evaluation of small molecule inhibitors of CD4-gp120 binding based on virtual screening

The low-molecular-weight compound JRC-II-191 inhibits infection of HIV-1 by blocking the binding of the HIV-1 envelope glycoprotein gp120 to the CD4 receptor and is therefore an important lead in the development of a potent viral entry inhibitor. Reported here is the use of two orthogonal screening methods, gold docking and ROCS shape-based similarity searching, to identify amine-building blocks that, when conjugated to the core scaffold, yield novel analogs that maintain similar affinity for gp120. Use of this computational approach to expand SAR produced analogs of equal inhibitory activity but with diverse capacity to enhance viral infection. The novel analogs provide additional lead scaffolds for the development of HIV-1 entry inhibitors that employ protein-ligand interactions in the vestibule of gp120 Phe 43 cavity.

SIX-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS

The present invention provides compounds of Formula (I), or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, B, R3 and R11 are as defined herein. The compounds of Formula (I) are useful as selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; for example thrombin, factor Xa, factor XIa, factor IXa, factor VIIa and/or plasma kallikrein. In particular, it relates to compounds that are selective factor XIa inhibitors or dual inhibitors of fXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.

Synthesis and characterization of N-acylaniline derivatives as potential chemical hybridizing agents (CHAs) for wheat (Triticum aestivum L.)

Induction of male sterility by deployment of chemical hybridizing agents (CHAs) are important in heterosis breeding of self-pollinated crops like wheat, wherein the male and female organs are in the same flower. Taking a lead from the earlier work on rice, a total of 25 N-acylanilines comprising of malonanilates, acetoacetanilides, and acetanilides (including halogenated acetanilides) were synthesized and screened as CHAs on three genotypes of wheat, viz., PBW 343, HD 2046, and HD 2733 at 1500 ppm in the winter of 2001-2002. The N-acylanilines containing variations at the acyl and aromatic domain were synthesized by condensation of substituted anilines with appropriate diesters, acid chlorides, or monoesters. The test compounds with highly electronegative groups such as F/Br at the para position of the aryl ring were identified as the most potent CHAs, causing higher induction of male sterility. A variation of N-substitution at the side chain generally furnished analogues like 4′-fluoroacetoacetanilide (7) and ethyl 4′-fluoromalonanilate (1), which induced 89.12 and 84.66% male sterility, respectively, in PBW 343. Among halogenated acetanilides, the increasing number of chlorine atoms in the side chain led to an increase in the activity of 4′-fluoro (23) and 4′-bromo (24) derivatives of trichoroacetanilides, which induced >87% male sterility. Quantitative structure-activity relationship (QSAR) models indicated the positive contributions of the field effect exemplified by the Swain-Lupton constant (Fp) and negative contributions of the Swain-Lupton resonance constant (R) for the aromatic substitution. The positive influences of parachor (P) for the acyl domain have been underlined. These leads will be significant in explaining the CHA fit in the macromolecular receptor site. The CHAs appeared to act by causing an imbalance in the acid-base equilibrium in pollen mother cells resulting in dissolution of the callose wall by premature callase secretion.